- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05787080
Massage, Oxidative and Antioxidant Enzymes in Hemodialysis Patients With Restless Legs Syndrome(RLS) (RLS)
The Effect of Massage on Oxidative and Antioxidant Enzymes in Hemodialysis Patients With Restless Legs Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this study, the following research hypotheses will be tested. H0a: Individuals with restless legs syndrome receiving hemodialysis treatment; In the second hour of hemodialysis, massage applied to both calf muscles for 10 minutes three times a week for one month is not affect the oxidative and antioxidant enzymes of the patients.
H1a: Individuals with restless legs syndrome receiving hemodialysis treatment; In the second hour of hemodialysis, massage applied to both calf muscles for 10 minutes three times a week for one month is effective on the oxidative and antioxidant enzymes of the patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Türkiye
-
Ankara, Türkiye, Turkey, 109861
- Başkent University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Receiving hemodialysis treatment for at least 6 months, 3 days a week for 4 hours,
- Patients with RLS according to the diagnostic criteria of the International RLS study group,
- No psychiatric problems,
- No neurological deficit,
- Exercise and physical therapy modalities have not been applied in the last year,
- In the laboratory examinations, the kinetic indicators of dialysis adequacy are within the desired target range (Kt/V: 1.2-1.3; URR: 60-65%), and there are no pathological findings (fracture, dislocation, tumor, infection) in the radiological examinations. .
Exclusion Criteria:
- Hemiplegic patients
- Patients with heart failure
- Individuals with chronic obstructive pulmonary diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Massage Group/experimental
Blood tests will be taken at the entrance of dialysis from all participants.
Then, in the second hour of hemodialysis, low voltage vibrations will be applied to both calf muscles of the patients for 10 minutes, three times a week for one month.Vibration application will be made with this device 53 Hz head.
The vibration application will be performed for 2.5 minutes, starting from the medial side of the gastrocnemius (calf) muscle in both legs and moving it longitudinally from distal to proximal and from back to distal in a straight line within 20 seconds.
Then this treatment will be applied to the lateral side of the gastrocnemius muscle for 2.5 minutes.
This cycle will be repeated twice.
After the one-month application period is completed, blood tests will be taken from all participants at the entrance to hemodialysis.
|
In the second hour of hemodialysis, vibration is applied to both calf muscles of the patients for 10 minutes three times a week for four weeks at low voltages.
|
No Intervention: Control Group
No intervention will be made on the patients in the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Malondialdehyde (MDA) levels of RLS patients
Time Frame: 1 week
|
In patients diagnosed with RLS, their blood will be taken on the same day and their plasma will be collected by centrifugation.
In RLS patients, cells are expected to undergo lipid peroxidation depending on the disease.
This causes cell and tissue damage due to oxidative stress.
Damage can also increase the severity and extent of the pain.
For this reason, the degree of degradation will be determined by measuring the color reaction-based concentration (nmol/ml plasma) formed as a result of the reaction of malondialdehyde, the degradation product of lipids, which is an indicator of lipid peroxidation, with thiobarbituric acid (TBA).
|
1 week
|
Erythrocyte Reducte Glutathione (GSH) levels of RLS patients
Time Frame: 1 week
|
Reduced glutathione is needed to stay healthy and prevent disease and protect from the effects of aging, immune function and control of inflammation.
After adding an equal amount of 10% TCA to plasma samples from 24 RLS patients.
It was centrifuged at 4000 rpm at +4ºC for 10 minutes.
0.5 ml of the upper phase is taken and 2 ml of 0.3 M Na2HPO4, 2H2O and 0.2 ml of dithiobisnitro benzoic acid are added on it, and then 412 nm. will be read in the spectrophotometer and their concentrations will be given in terms of micromole (µmol) / ml plasma.
This will also confirm the concentration of lipid peroxidation present.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of vibration massage on blood level of Malondialdehyde
Time Frame: 1 week
|
It is expected that a decrease in the concentration of MDA and an increase in the rate of reduced glutathione (GSH) are expected, since it is thought that the vibration vibration massage applied to the same patients may cause the intercellular fluid and blood mobilization due to heat and vibration on the muscle tissue, thereby lowering the pain threshold.
|
1 week
|
Effect of vibration massage on blood level of Erythrocyte Reducte Glutathione
Time Frame: 1 week
|
It is expected that a decrease in the concentration of MDA and an increase in the rate of reduced glutathione (GSH) are expected, since it is thought that the vibration vibration massage applied to the same patients may cause the intercellular fluid and blood mobilization due to heat and vibration on the muscle tissue, thereby lowering the pain threshold.
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Nervous System Diseases
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Kidney Diseases
- Urologic Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease Attributes
- Disease
- Dyskinesias
- Psychomotor Disorders
- Parasomnias
- Renal Insufficiency, Chronic
- Chronic Disease
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Syndrome
- Psychomotor Agitation
- Restless Legs Syndrome
- Kidney Failure, Chronic
- Renal Insufficiency
Other Study ID Numbers
- G Turgay
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Restless Legs Syndrome
-
Walter Reed National Military Medical CenterWithdrawnEkbom Syndrome | Restless Legs Syndrome, | Restless Legs,United States
-
XenoPort, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
GlaxoSmithKlineCompletedRestless Legs Syndrome | Restless Legs Syndrome (RLS)United States
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs Syndrome
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
Astellas Pharma IncCompletedRestless Legs Syndrome (RLS)Japan
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs SyndromeJapan
-
UCB PharmaCompletedIdiopathic Restless Legs SyndromeGermany
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedIdiopathic Restless Legs SyndromeUnited States, Spain, Finland, Italy, Germany, Sweden, Austria, Netherlands, United Kingdom
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)
Clinical Trials on Massage
-
Chulalongkorn UniversityCompletedIschemic StrokeThailand
-
TC Erciyes UniversityCompletedAbdominal Pain | Satisfaction, Patient | DistentionTurkey
-
Mayo ClinicCompletedFatigue | Stress | Anxiety | TensionUnited States
-
São Paulo State UniversityFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
University of ValenciaCompletedHamstring ContracturesSpain
-
muxing zhuRecruiting
-
Emre ErkalRecruiting
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedMusculoskeletal ManipulationsFrance
-
Mersin UniversityCompletedHemodialysis PatientsTurkey
-
Universitat Internacional de CatalunyaUnknown